← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Asuragen, Inc.
Austin, TX
$12,697,498
Total funding
24
Grants
Funding over time
peak $2.3M · FY2009–19$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,697,498 · 24
By mechanism
R44$7,179,142 · 6
R43$3,787,818 · 16
N44$1,489,494 · 1
N43$241,044 · 1
Investigators at Asuragen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
IGF::OT::IGF BCR-ABL 1 RT-QPCR TEST FOR IMPROVED MONITORING OF CML$1,489,494
N44 · FY2015 · CA
Enabling use of blood spot cards for accurate high throughput Fragile X screening$1,142,346
R44 · FY2013 · HD
Enabling use of blood spot cards for accurate high throughput Fragile X screening$1,011,519
R44 · FY2014 · HD
Integrated Bioinformatics Analysis Suite for targeted NGS of clinical specimens$876,128
R44 · FY2014 · GM
Development of an information-rich assay for C9ORF72 as a test for ALS and FTD$759,812
R44 · FY2017 · NS
Technologies for Mapping Interspersed AGG Sequences in the FMR1 Gene$706,648
R44 · FY2011 · HD
Development of an information-rich assay for C9ORF72 as a test for ALS and FTD$619,938
R44 · FY2016 · NS
Technologies for Mapping Interspersed AGG Sequences in the FMR1 Gene$615,151
R44 · FY2012 · HD
Identification of microRNA Biomarkers for Colon Cancer Recurrence Risk Stratifica$590,860
R44 · FY2011 · CA
Enabling use of blood spot cards for accurate high-throughput Fragile X screening$346,302
R43 · FY2011 · HD
Development of clinical triage assay for sepsis management in the Emergency Room$314,420
R43 · FY2013 · GM
Identification of microRNA Biomarkers for Colon Cancer Recurrence Risk Stratifica$301,582
R44 · FY2012 · CA
AmplideX DeepNet, a new paradigm for deep learning analytical tools in the molecular diagnostic space$269,217
R43 · FY2019 · GM
Integrated Bioinformatics Analysis Suite for targeted NGS of clinical specimens$263,998
R44 · FY2015 · GM
Quantitative Superplexing: Single-tube, many-target qPCR for cancer diagnostics$246,864
R43 · FY2015 · CA
Integrated Bioinformatics Analysis Suite for deep, targeted amplicon sequencing$242,940
R43 · FY2012 · HG
BCR-ABL1 RT-qPCR Test for improved monitoring of CML$241,044
N43 · FY2013 · CA
Novel Strategies for Enhanced Detection of Hemoglobinopathy Carriers$231,153
R43 · FY2019 · HL
Comprehensive Solution for Transcriptome Profiling of Archived Tissues$225,000
R43 · FY2014 · ES
Development of a reliable and standardized molecular assay for fragile x protein$225,000
R43 · FY2015 · HD